Bausch Health Companies’ (BHC) Hold Rating Reaffirmed at Jefferies Financial Group

Jefferies Financial Group reiterated their hold rating on shares of Bausch Health Companies (NYSE:BHC) in a report issued on Thursday,Benzinga reports. The brokerage currently has a $8.00 target price on the stock, down from their previous target price of $12.00.

A number of other research firms also recently commented on BHC. StockNews.com upgraded shares of Bausch Health Companies from a “hold” rating to a “buy” rating in a research note on Friday, October 25th. Royal Bank of Canada cut their price objective on Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating on the stock in a research note on Thursday, January 30th. Finally, Evercore ISI upgraded Bausch Health Companies to a “hold” rating in a research report on Tuesday, October 15th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $7.42.

Bausch Health Companies Stock Down 10.8 %

BHC stock opened at $6.55 on Thursday. The company has a market capitalization of $2.37 billion, a PE ratio of -13.64 and a beta of 0.68. The stock’s 50 day moving average is $7.69 and its two-hundred day moving average is $7.45. Bausch Health Companies has a 52-week low of $3.96 and a 52-week high of $11.46.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. LMR Partners LLP acquired a new position in shares of Bausch Health Companies during the third quarter valued at $3,264,000. Intact Investment Management Inc. bought a new stake in Bausch Health Companies in the 3rd quarter valued at about $1,543,000. XTX Topco Ltd acquired a new position in Bausch Health Companies during the 3rd quarter valued at about $938,000. SG Americas Securities LLC grew its position in Bausch Health Companies by 62.0% in the 4th quarter. SG Americas Securities LLC now owns 3,301,981 shares of the company’s stock worth $26,614,000 after purchasing an additional 1,263,706 shares during the last quarter. Finally, Range Financial Group LLC acquired a new stake in shares of Bausch Health Companies in the fourth quarter valued at approximately $1,004,000. 78.65% of the stock is currently owned by institutional investors.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.